RGD Reference Report - The role of cyclins and cyclins inhibitors in the multistep process of HPV-associated cervical carcinoma. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

The role of cyclins and cyclins inhibitors in the multistep process of HPV-associated cervical carcinoma.

Authors: Bahnassy, AA  Zekri, AR  Alam El-Din, HM  Aboubakr, AA  Kamel, K  El-Sabah, MT  Mokhtar, NM 
Citation: Bahnassy AA, etal., J Egypt Natl Canc Inst. 2006 Dec;18(4):292-302.
RGD ID: 2293574
Pubmed: PMID:18301453   (View Abstract at PubMed)

BACKGROUND: Human papillomavirus (HPV) types 16 and 18 are associated with cervical carcinogenesis. This is possibly achieved through an interaction between HPV oncogenic proteins and some cell cycle regulatory genes. However, the exact pathogenetic mechanisms are not well defined yet. METHODS: We investigated 110 subjects (43 invasive squamous cell carcinoma (ISCC), 38 CIN III, 11 CIN II, 18 CIN I) confirmed to be positive for HPV16 and/or 18 as well as 20 normal cervical tissue (NCT) samples for abnormal expression of cyclin D1, cyclin E, CDK4, cyclin inhibitors (p21 (waf), p27, p16 (INK4A)) and Ki-67 using immunohistochemistry and differential PCR techniques. RESULTS: There was a significant increase in the expression of Ki-67, cyclin E, CDK4, p16 (INK4A) (p=0.003, 0.001, 0.001) and a significant decrease in p27 (Kip1) from NCT to ISCC (p=0.003). There was a significant correlation between altered expression of p27 (KIP1) and p16(INK4A) (p<0.001), cyclin D1 and CDK4 (p=0.001), cyclin E and p27 (Kip1) (p=0.011) in all studied groups. In ISCC, there was significant relationship between standard clinicopathological prognostic factors and high Ki-67 index , increased cyclin D1 and cyclin E, reduced p27 (Kip1) and p21 (waf). CONCLUSION: 1) Aberrations involving p27 (KIP1), cyclin E, CDK4 and p16 (INK4A) are considered early events in HPV 16 and 18-associated cervical carcinogenesis (CINI & II), whereas cyclin D1 aberrations are late events (CINIII & ISCC) 2) Immunohistochemical tests for p16 (INK4A) and cyclin E could help in early diagnosis of cervical carcinoma 3) Only FIGO stage, cyclin D1, p27 (Kip1) and Ki-67 are independent prognostic factors that might help in predicting outcome of cervical cancer patients.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
CCND1Humancervix uteri carcinoma in situ  IEP protein:increased expression:uterine cervixRGD 
CCNE1Humancervix uteri carcinoma in situ  IEP protein:increased expression:uterine cervixRGD 
CDK4Humancervix uteri carcinoma in situ disease_progressionIEP associated with Papillomavirus Infections and protein:increased expression:cervix epitheliumRGD 
CDKN1BHumancervix uteri carcinoma in situ disease_progressionIEP associated with Papillomavirus Infections and protein:decreased expression:cervical epitheliumRGD 
Ccnd1Ratcervix uteri carcinoma in situ  ISOCCND1 (Homo sapiens)protein:increased expression:uterine cervixRGD 
Ccnd1Mousecervix uteri carcinoma in situ  ISOCCND1 (Homo sapiens)protein:increased expression:uterine cervixRGD 
Ccne1Ratcervix uteri carcinoma in situ  ISOCCNE1 (Homo sapiens)protein:increased expression:uterine cervixRGD 
Ccne1Mousecervix uteri carcinoma in situ  ISOCCNE1 (Homo sapiens)protein:increased expression:uterine cervixRGD 
Cdk4Ratcervix uteri carcinoma in situ disease_progressionISOCDK4 (Homo sapiens)associated with Papillomavirus Infections and protein:increased expression:cervix epitheliumRGD 
Cdk4Mousecervix uteri carcinoma in situ disease_progressionISOCDK4 (Homo sapiens)associated with Papillomavirus Infections and protein:increased expression:cervix epitheliumRGD 
Cdkn1bRatcervix uteri carcinoma in situ disease_progressionISOCDKN1B (Homo sapiens)associated with Papillomavirus Infections and protein:decreased expression:cervical epitheliumRGD 
Cdkn1bMousecervix uteri carcinoma in situ disease_progressionISOCDKN1B (Homo sapiens)associated with Papillomavirus Infections and protein:decreased expression:cervical epitheliumRGD 
CDK4HumanUterine Cervical Neoplasms disease_progressionIEP associated with Papillomavirus Infections and protein:increased expression:cervix epitheliumRGD 
CDKN1BHumanUterine Cervical Neoplasms disease_progressionIEP associated with Papillomavirus Infections and protein:decreased expression:cervical epitheliumRGD 
Cdk4MouseUterine Cervical Neoplasms disease_progressionISOCDK4 (Homo sapiens)associated with Papillomavirus Infections and protein:increased expression:cervix epitheliumRGD 
Cdk4RatUterine Cervical Neoplasms disease_progressionISOCDK4 (Homo sapiens)associated with Papillomavirus Infections and protein:increased expression:cervix epitheliumRGD 
Cdkn1bRatUterine Cervical Neoplasms disease_progressionISOCDKN1B (Homo sapiens)associated with Papillomavirus Infections and protein:decreased expression:cervical epitheliumRGD 
Cdkn1bMouseUterine Cervical Neoplasms disease_progressionISOCDKN1B (Homo sapiens)associated with Papillomavirus Infections and protein:decreased expression:cervical epitheliumRGD 

Objects Annotated

Genes (Rattus norvegicus)
Ccnd1  (cyclin D1)
Ccne1  (cyclin E1)
Cdk4  (cyclin-dependent kinase 4)
Cdkn1b  (cyclin-dependent kinase inhibitor 1B)

Genes (Mus musculus)
Ccnd1  (cyclin D1)
Ccne1  (cyclin E1)
Cdk4  (cyclin dependent kinase 4)
Cdkn1b  (cyclin dependent kinase inhibitor 1B)

Genes (Homo sapiens)
CCND1  (cyclin D1)
CCNE1  (cyclin E1)
CDK4  (cyclin dependent kinase 4)
CDKN1B  (cyclin dependent kinase inhibitor 1B)


Additional Information